| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.099 | 0.002 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.16 | 0.003 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.004 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.096 | 0.004 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.14 | 0.004 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.005 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |